Grifols, S.A. Total Liabilities 2011-2026 | GRFS

Annual Total Liabilities Grifols, S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
12.8 B	13.5 B	13.3 B	11.9 B	8.55 B	8.7 B	7.78 B	7.29 B	6.4 B	6.3 B	5.79 B	3.75 B	3.75 B	4.14 B

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
13.5 B	3.75 B	8.14 B

Quarterly Total Liabilities Grifols, S.A.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	11.9 B	-	-	-	8.55 B	-	-	-	8.7 B	-	-	-	7.78 B	-	-	-	7.29 B	-	-	-	6.4 B	-	-	-	6.3 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
11.9 B	6.3 B	8.13 B

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
BioNTech SE BNTX	2.76 B	$ 95.5	-3.88 %	$ 27.2 B	Germany
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	64.4 M	-	-	$ 269 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
ACADIA Pharmaceuticals ACAD	455 M	$ 22.35	0.72 %	$ 3.7 B	USA
Galapagos NV GLPG	171 M	$ 28.39	-0.13 %	$ 2.69 B	Belgium
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 3.5	5.42 %	$ 5.76 M	Israel
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
InflaRx N.V. IFRX	13.7 M	$ 1.97	-7.51 %	$ 152 M	Germany
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	243 M	$ 23.42	-0.3 %	$ 2.98 B	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	7.24 M	-	10.36 %	$ 9.8 M	USA
Applied Therapeutics APLT	72 M	-	-	$ 8.42 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	38.9 M	-	17.91 %	$ 11.1 M	USA
Innate Pharma S.A. IPHA	151 M	$ 1.4	-2.1 %	$ 235 M	France
CRISPR Therapeutics AG CRSP	343 M	$ 52.38	-2.24 %	$ 4.71 B	Schweiz
Avenue Therapeutics ATXI	1.1 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	411 M	$ 1.64	4.46 %	$ 436 M	Britain
Inventiva S.A. IVA	226 M	$ 5.42	2.85 %	$ 138 M	France
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	195 M	-	-	-	Russia
Фармсинтез LIFE	1.04 B	-	-	-	Russia
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
Atreca BCEL	76.6 M	-	-11.76 %	$ 5.79 M	USA